Boehringer Ingelheim Pharmaceuticals recalls
Boehringer Ingelheim Pharmaceuticals has 13 recalls on record with the FDA and USDA, the earliest in 2016 and the latest reported on 8 Jul 2026. 1 is still ongoing. 1 was reported in the last 12 months. The most frequent reason is potency & assay.
Total recalls 13 since 2016
Last 12 months 1 reported
Class I 0 0% of total
Ongoing 1 latest 8 Jul 2026
Recalls per month, last 24 months click a bar for that month Severity split
0 0%11 85%2 15%
Why boehringer ingelheim pharmaceuticals is recalled
Ongoing boehringer ingelheim pharmaceuticals recalls 1 active
All boehringer ingelheim pharmaceuticals recalls, newest first 13 total Reported Class Recall Company Reason Where 8 Jul 2026 Drug CLASS II Synjardy XR Tablets (empagliflozin recalled by Boehringer Ingelheim Boehringer Ingelheim Pharmaceuticals Manufacturing (CGMP) Deviations OH 29 Mar 2023 Drug CLASS II Jardiance (Empagliflozin) recalled by Boehringer Ingelheim Jardiance Boehringer Ingelheim Pharmaceuticals Packaging Defects Nationwide 9 Jun 2021 Drug CLASS II Micardis Tablets, (telmisartan Tablets) 80 mg per folding recalled Boehringer Ingelheim Pharmaceuticals Potency & Assay 11 states 4 Nov 2020 Drug CLASS II Catapres (clonidine hydrochloride, USP) 0.3 mg, tablet recalled Boehringer Ingelheim Pharmaceuticals Foreign Material Nationwide 4 Nov 2020 Drug CLASS II Catapres (clonidine hydrochloride, USP) 0.2 mg, tablet recalled Boehringer Ingelheim Pharmaceuticals Foreign Material Nationwide 4 Nov 2020 Drug CLASS II Catapres (clonidine hydrochloride, USP) 0.1 mg, tablet recalled Boehringer Ingelheim Pharmaceuticals Foreign Material Nationwide 20 Mar 2019 Drug CLASS III Mirapex (pramipexole dihydrochloride) Tablets recalled Boehringer Ingelheim Pharmaceuticals Potency & Assay Nationwide 7 Nov 2018 Drug CLASS II Catapres .2 (clonidine hydrochloride, USP) 0.2mg recalled Boehringer Ingelheim Pharmaceuticals Potency & Assay Nationwide 3 Oct 2018 Drug CLASS II Synjardy (empagliflozin and metformin hydrochloride) Tablets recalled Synjardy Boehringer Ingelheim Pharmaceuticals Other Nationwide 7 Feb 2018 Drug CLASS II Spiriva HandiHaler (tiotropium bromide inhalation powder) recalled Spiriva Boehringer Ingelheim Pharmaceuticals Potency & Assay Nationwide 18 Oct 2017 Drug CLASS III Mobic (meloxicam) tablets, 15 mg, package recalled Boehringer Ingelheim Pharmaceuticals Packaging Defects CO, OH 2 Nov 2016 Drug CLASS II Dipyridamole Tablets USP, 75 mg recalled by Boehringer Ingelheim Boehringer Ingelheim Pharmaceuticals Other Nationwide 2 Nov 2016 Drug CLASS II Persantine (dipyridamole USP) tablets, 75 mg recalled Boehringer Ingelheim Pharmaceuticals Other Nationwide
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.